Document Detail


Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.
MedLine Citation:
PMID:  17697875     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Visceral fat is highly correlated with metabolic syndrome in obese adolescents. The aims of this study were to determine the prevalence of metabolic syndrome and to assess the effect of a long-term (1 year) intervention with multidisciplinary therapy in predicting metabolic syndrome among obese adolescents, as well as to compare short- with long-term therapy. Eighty-three postpuberty obese adolescents were recruited, including 37 boys (body mass index [BMI], 36.19 +/- 3.85 kg/m(2)) and 46 girls (BMI, 35.73 +/- 4.42 kg/m(2)). Body composition was measured by plethysmography using the BOD POD body composition system (version 1.69, Life Measurement Instruments, Concord, CA), and visceral fat was analyzed by ultrasound. Metabolic syndrome was determined according to the World Health Organization criteria. Patients were assigned to a weight loss multidisciplinary intervention consisting of nutritional, exercise, psychological, and clinical therapy. At the beginning of therapy, we found that 27.16% of the obese adolescents presented metabolic syndrome, whereas only 8.3% did so after intervention. Indeed, in boys, BMI (36.19 +/- 3.85 to 32.06 +/- 5.85 kg/m(2)), visceral fat (4.88 +/- 1.35 to 3.63 +/- 1.71 cm), homeostasis model assessment of insulin resistance (4.77 +/- 3.41 to 3.18 +/- 2.33), and percentage of body fat (38.24% +/- 6.54% to 30.02% +/- 13.43%) presented a statistically significant reduction; and their fat-free mass percentage increased (62.14% +/- 5.78% to 69.17% +/- 12.37%). In girls, after long-term therapy, BMI (35.73 +/- 4.42 to 33.62 +/- 3.78 kg/m(2)), visceral fat (3.70 +/- 1.40 to 2.75 +/- 1.01 cm), and percentage of body fat (46.10% +/- 5.66% to 39.91% +/- 5.59%) showed a statistically significant reduction; and their fat-free mass increased (53.61% +/- 5.65% to 59.82% +/- 5.78%). In conclusion, long-term multidisciplinary therapy was effective in promoting beneficial changes in some predictors and decreasing the prevalence of metabolic syndrome in obese adolescents.
Authors:
Danielle Arisa Caranti; Marco Túlio de Mello; Wagner L Prado; Lian Tock; Kãli O Siqueira; Aline de Piano; Mara C Lofrano; Dejaldo M J Cristofalo; Henrique Lederman; Sérgio Tufik; Ana R Dâmaso
Related Documents :
2401585 - Reduction of lipoprotein (a) by weight loss.
7088775 - The cellular basis for growth of the abdominal fat pad in broiler-type chickens.
9625085 - Fat distribution and hemostatic measures in obese children.
18776705 - Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carot...
8576945 - Effect of dietary antioxidant trace element supply on cardiac tolerance to ischemia-rep...
648225 - Chylothorax as a manifestation of rheumatic mitral stenosis: its postoperative manageme...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  56     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-16     Completed Date:  2007-10-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1293-300     Citation Subset:  IM    
Affiliation:
Post Graduate Program of Nutrition, Federal University of São Paulo, São Paulo, Brazil. danicaranti.pnut@epm.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Body Fat Distribution
Body Weight
Combined Modality Therapy*
Diet Therapy
Exercise Therapy
Female
Humans
Intra-Abdominal Fat / anatomy & histology
Male
Metabolic Syndrome X / complications,  epidemiology,  metabolism,  therapy*
Obesity / complications,  metabolism,  therapy*
Patient Compliance
Prevalence
Psychotherapy
Risk Reduction Behavior
Subcutaneous Fat / anatomy & histology
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improve...
Next Document:  Quantitative measurements of integrin-mediated adhesion to extracellular matrix.